Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03873129 · ClinicalTrials.gov registry record · NA
ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction
A NA study of Substance Use Disorders and HIV/AIDS, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT03873129: Completed NA study of Substance Use Disorders and HIV/AIDS, sponsored by University of Wisconsin, Madison.
NCT03873129 is a NA study of Substance Use Disorders and HIV/AIDS that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 208 participants, below the 498-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03873129, a NA study of Substance Use Disorders and HIV/AIDS, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
It is now well-accepted that lowering community-level viral load through expansion of antiretroviral therapy (ART) can reduce HIV transmission among people who use drugs. However, achieving durable viral suppression among patients with substance use disorders is a major challenge for providers and health systems. This study aims to adapt and implement an existing mobile health (mHealth) system, A-CHESS (Addiction Comprehensive Health Enhancement Support System) to improve care for HIV patients with substance use disorders.
Primary Outcome
Viral suppression will be measured each 6 months period. HIV RNA\< 200 copies/mL reflects viral suppression per protocol.
Conditions Studied
Interventions
- BEHAVIORAL mobile health app (mHealth)
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2019-03-12 |
| Est. Completion | 2021-04-12 |
| Phase | NA |
What the finished NCT03873129 record still lists
NCT03873129 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which mobile health app (mHealth) is the first listed.
NCT03873129 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03873129 about?
NCT03873129 is a clinical study titled "ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction". It is now well-accepted that lowering community-level viral load through expansion of antiretroviral therapy (ART) can reduce HIV transmission among people who use drugs. However, achieving durable viral suppression among patients with substance use disorders is a major challenge for providers and h...
What is the current status of trial NCT03873129?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2019-03-12. Estimated completion is 2021-04-12.
What conditions does trial NCT03873129 study?
This clinical trial studies the following conditions: Substance Use Disorders, HIV/AIDS.
What interventions are being tested in trial NCT03873129?
The interventions under investigation include: mobile health app (mHealth) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03873129?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03873129 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03873129's enrollment target sits among peer trials
208 32nd of 93 higher than 61 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI